Star Therapeutics
Recent Finacing
Series C
Recent Raise
$90M
Star Therapeutics is a biotechnology company that develops first-in-class antibody therapies, primarily for hematology and immunology, and also generates additional biotech companies focused on discovering and advancing novel antibody therapies.
Focus Areas
Biotechnology
Antibody Therapies
Hematology/Immunology
Investors